Celator Pharmaceuticals
Operator of a pharmaceutical company intended to improve clinical outcomes.
Launch date
Market cap
-
Enterprise valuation
$1.5b (Public information from May 2016)
Dublin County Dublin (HQ)
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
N/A | Seed | ||
$20.0m | Series B | ||
N/A | $10.0m | Series C | |
$22.5m | Series C | ||
N/A | $2.5m | Early VC | |
$20.0m | Series D | ||
N/A | $2.6m | Early VC | |
$39.3m | Growth Equity VC | ||
N/A | N/A | IPO | |
$15.0m | Debt | ||
$1.5b Valuation: $1.5b | Acquisition | ||
Total Funding | $117m |